EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial

Marc-André d'Entremont, Sulaiman Alrashidi, Omar Alansari, Bradley Brochu, Laura Heenan, Elizabeth Skuriat, Jessica Tyrwhitt, Micheal Raco, Micheal Tsang, Nicholas Valettas, James L Velianou, Tej N Sheth und 16 weitere

EuroIntervention · 2023-05 · 19 (1) · 73-79

DOI: 10.4244/eij-d-22-01130 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2023-05. Verfasst von Marc-André d'Entremont und 27 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, QC, Canada. Hauptthemen laut MEDLINE: Vascular Closure Devices, Cardiovascular Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Whether ultrasound (US)-guided femoral access compared to femoral access without US guidance decreases access site complications in patients receiving a vascular closure device (VCD) is unclear. AIMS: We aimed to compare the safety of VCD in patients undergoing US-guided versus non-US-guided femoral arterial access for coronary procedures. METHODS: We performed a prespecified subgroup analysis of the UNIVERSAL trial, a multicentre randomised controlled trial of 1:1 US-guided femoral access versus non-US-guided femoral access, stratified for planned VCD use, for coronary procedures on a background of fluoroscopic landmarking. The primary endpoint was a composite of major Bleeding Academic Research Consortium 2, 3 or 5 bleeding and vascular complications at 30 days. RESULTS: Of 621 patients, 328 (52.8%) received a VCD (86% ANGIO-SEAL, 14% ProGlide). In patients who received a VCD, those randomised to US-guided femoral access compared to non-US-guided femoral access experienced a reduction in major bleeding or vascular complications (20/170 [11.8%] vs 37/158 [23.4%], odds ratio [OR] 0.44, 95% confidence interval [CI]: 0.23-0.82). In patients who did not receive a VCD, there was no difference between the US- and non-US-guided femoral access groups, respectively (20/141 [14.2%] vs 13/152 [8.6%], OR 1.76, 95% CI: 0.80-4.03; interaction p=0.004). CONCLUSIONS: In patients receiving a VCD after coronary procedures, US-guided femoral access was associated with fewer bleeding and vascular complications compared to femoral access without US guidance. US guidance for femoral access may be particularly beneficial when VCD are used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Closure DevicesCardiovascular DiseasesHumansHemostatic TechniquesFemoral ArteryHemorrhageUltrasonography, InterventionalTreatment Outcome

Autor:innen und Institutionen

  • Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, QC, Canada.
  • Population Health Research Institute, Hamilton, ON, Canada.
  • McMaster University, Hamilton, ON, Canada.
  • Hamilton Health Sciences, Hamilton, ON, Canada.
  • Niagara Health, St. Catharines, ON, Canada.
  • CK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, AB, Canada.

Zitieren

APA

d'Entremont, M. A., Alrashidi, S., Alansari, O., Brochu, B., Heenan, L., Skuriat, E., Tyrwhitt, J., Raco, M., Tsang, M., Valettas, N., Velianou, J. L., Sheth, T. N., Sibbald, M., Mehta, S. R., Pinilla-Echeverri, N., Schwalm, J. D., Natarajan, M. K., Kelly, A., Akl, E., …, & Jolly, S. S. (2023). Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial. EuroIntervention, 19(1), 73-79. https://doi.org/10.4244/eij-d-22-01130

Vancouver

d'Entremont MA, Alrashidi S, Alansari O, Brochu B, Heenan L, Skuriat E, et al. Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial. EuroIntervention. 2023;19(1):73-79. doi:10.4244/eij-d-22-01130

BibTeX
@article{dEntremont2023,
  author = {d'Entremont, Marc-André and Alrashidi, Sulaiman and Alansari, Omar and Brochu, Bradley and Heenan, Laura and Skuriat, Elizabeth and Tyrwhitt, Jessica and Raco, Micheal and Tsang, Micheal and Valettas, Nicholas and Velianou, James L and Sheth, Tej N and Sibbald, Matthew and Mehta, Shamir R and Pinilla-Echeverri, Natalia and Schwalm, Jon David and Natarajan, Madhu K and Kelly, Andrew and Akl, Elie and Tawadros, Sarah and Camargo, Mercedes and Faidi, Walaa and Bauer, John and Moxham, Rachel and Nkurunziza, James and Dutra, Gustavo and Winter, Jose and Jolly, Sanjit S},
  title = {Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial},
  journal = {EuroIntervention},
  year = {2023},
  volume = {19},
  number = {1},
  pages = {73--79},
  doi = {10.4244/eij-d-22-01130}
}
Kostenlos starten →